Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03598608 |
|---|---|
| Brief Title: | Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003) |
| First Submitted : | July 16, 2018 |
| First Submitted that Met QC Criteria : | July 16, 2018 |
| First Posted : | July 26, 2018 |
| Last Update Submitted that Met QC Criteria : | October 13, 2022 |
| Last Update Posted : | October 14, 2022 |